Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 34, 2018 - Issue 6
453
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

In vitro antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces

ORCID Icon, , , , , & ORCID Icon show all
Pages 699-709 | Received 05 Feb 2018, Accepted 30 May 2018, Published online: 06 Sep 2018

References

  • Arunasree KM. 2010. Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB231. Phytomedicine. 17:581–588. doi:10.1016/j.phymed.2009.12.008
  • Banzi ÉC, Costa AR, Puppin-Rontani RM, Babu J, García-Godoy F. 2014. Inhibitory effects of a cured antibacterial bonding system on viability and metabolic activity of oral bacteria. Dent Mater. 30:238–244. doi:10.1016/j.dental.2014.04.007
  • Baser KH. 2008. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des. 14:3106–3119. doi:10.2174/138161208786404227
  • Basso FG, Oliveira CF, Kurachi C, Hebling J, de Souza Costa CA. 2013. Biostimulatory effect of low-level laser therapy on keratinocytes in vitro. Lasers Med Sci. 28:367–374. doi:10.1007/s10103-012-1057-8
  • Belibasakis GN. 2014. Microbiological and immuno-pathological aspects of peri-implant diseases. Arch Oral Biol. 59:66–72. doi:10.1016/j.archoralbio.2013.09.013
  • Bhakkiyalakshmi E, Suganya N, Sireesh D, Krishnamurthi K, Saravana Devi S, Rajaguru P, Ramkumar KM. 2016. Carvacrol induces mitochondria-mediated apoptosis in HL-60 promyelocytic and Jurkat T lymphoma cells. Eur J Pharmacol. 772:92–98. doi:10.1016/j.ejphar.2015.12.046
  • Botelho MA, Nogueira NA, Bastos GM, Fonseca SG, Lemos TL, Matos FJ, Montenegro D, Heukelbach J, Rao VS, Brito GA. 2007. Antimicrobial activity of the essential oil from Lippia sidoides, carvacrol and thymol against oral pathogens. Braz J Med Biol Res. 40:349–356. doi:10.1590/S0100-879X2007000300010
  • Botelho MA, Martins JG, Ruela RS, I R, Santos JA, Soares JB, França MC, Montenegro D, Ruela WS, Barros LP et al. 2009. Protective effect of locally applied carvacrol gel on ligature-induced periodontitis in rats: a tapping mode AFM study. Phytother Res. 23:1439–1448. doi:10.1002/ptr.2798
  • Brindle ER, Miller DA, Stewart PS. 2011. Hydrodynamic deformation and removal of Staphylococcus epidermidis biofilms treated with urea, chlorhexidine, iron chloride, or DispersinB. Biotechnol Bioeng. 108:2968–2977. doi:10.1002/bit.23245
  • Busscher HJ, Rinastiti M, Siswomihardjo W, van der Mei HC. 2010. Biofilm formation on dental restorative and implant materials. J Dent Res. 89:657–665. doi:10.1177/0022034510368644
  • Catalán A, Pacheco JG, Martínez A, Mondaca MA. 2008. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 105:327–332. doi:10.1016/j.tripleo.2007.08.025
  • Ciandrini E, Campana R, Federici S, Manti A, Battistelli M, Falcieri E, Papa S, Baffone W. 2014. In vitro activity of Carvacrol against titanium-adherent oral biofilms and planktonic cultures. Clin Oral Investig. 18:2001–2013. doi:10.1007/s00784-013-1179-9
  • Corbin A, Pitts B, Parker A, Stewart PS. 2011. Antimicrobial penetration and efficacy in an in vitro oral biofilm model. Antimicrob Agents Chemother. 55:3338–3344. doi:10.1128/AAC.00206-11
  • Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG. 2000. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol. 88:170–175.
  • Dalleau S, Cateau E, Bergès T, Berjeaud JM, Imbert C. 2008. In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents. 31:572–576. doi:10.1016/j.ijantimicag.2008.01.028
  • Döll-Boscardin PM, Sartoratto A, Sales Maia BH, Padilha de Paula J, Nakashima T, Farago PV, Kanunfre CC. 2012. In vitro cytotoxic potential of essential oils of Eucalyptus benthamii and its related terpenes on tumor cell lines. Evid Based Complement Alternat Med. 2012:342652. doi:10.1155/2012/342652
  • Dusan F, Marián S, Katarína D, Dobroslava B. 2006. Essential oils-their antimicrobial activity against Escherichia coli and effect on intestinal cell viability. Toxicol in Vitro. 20:1435–1445. doi:10.1016/j.tiv.2006.06.012
  • Figuero E, Graziani F, Sanz I, Herrera D, Sanz M. 2014. Management of peri-implant mucositis and peri-implantitis. Periodontol 2000. 66:255–273. doi:10.1111/prd.12049
  • Gehrke SA, Zizzari VL, Iaculli F, Mortellaro C, Tetè S, Piattelli A. 2014. Relationship between the surface energy and the histologic results of different titanium surfaces. J Craniofac Surg. 25:863–867. doi:10.1097/SCS.0000000000000873
  • Gehrke SA, Ramírez-Fernandez MP, Granero Marín JM, Barbosa Salles M, Del Fabbro M, Calvo Guirado JL. 2016. A comparative evaluation between aluminium and titanium dioxide microparticles for blasting the surface titanium dental implants: an experimental study in rabbits. Clin Oral Implants Res. [2016 Sept 24]; [1–6]. doi: doi:10.1111/clr.12973.
  • Graziano TS, Calil CM, Sartoratto A, Franco GC, Groppo FC, Cogo-Müller K. 2016. In vitro effects of Melaleuca alternifolia essential oil on growth and production of volatile sulphur compounds by oral bacteria. J Appl Oral Sci. 24:582–589. doi:10.1590/1678-775720160044
  • Greay SJ, Ireland DJ, Kissick HTA, Levy MW, Beilharz TV, Riley CF, Carson CF. 2010. Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemother Pharmacol. 65:877–888. doi:10.1007/s00280-009-1093-7
  • Hahnel S, Rosentritt M, Handel G, Burgers R. 2008. Influence of saliva substitute films on initial Streptococcus mutans adhesion to enamel and dental substrata. J Dent. 36:977–983. doi:10.1016/j.jdent.2008.08.004
  • Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. 2000. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 49:619–626. doi:10.1007/s000110050639
  • Hammer KA, Dry L, Johnson M, Michalak EM, Carson CF, Riley TV. 2003. Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro. Oral Microbiol Immunol. 18:389–392. doi:10.1046/j.0902-0055.2003.00105.x
  • Houdkova M, Rondevaldova J, Doskocil I, Kokoska L. 2017. Evaluation of antibacterial potential and toxicity of plant volatile compounds using new broth microdilution volatilization method and modified MTT assay. Fitoterapia. 118:56–62. doi:10.1016/j.fitote.2017.02.008
  • Jin Y, Samaranayake LP, Samaranayake Y, Yip HK. 2004. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol. 49:789–798. doi:10.1016/j.archoralbio.2004.04.011
  • John G, Becker J, Schwarz F. 2015. Modified implant surface with slower and less initial biofilm formation. Clin Implant Dent Relat Res. 17:461–468. doi:10.1111/cid.12140
  • Kwiecinski J, Eick S, Wójcik K. 2009. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int J Antimicrob Agents. 33:343–347. doi:10.1016/j.ijantimicag.2008.08.028
  • Lambert RJW, Skandamis PN, Coote PJ, Nychas GJE. 2001. A study of the mínimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol. 91:453–462. doi:10.1046/j.1365-2672.2001.01428.x
  • Liang WZ, Lu CH. 2012. Carvacrol-induced [Ca2+] rise and apoptosis in human glioblastoma cells. Life Sci. 90:703–711. doi:10.1016/j.lfs.2012.03.027
  • Lindhe J, Meyle J. 2008. Peri-implant diseases: consensus report of the sixth European workshop on periodontology. J Clin Periodontol. 35:282–285. doi:10.1111/j.1600-051X.2008.01283.x
  • Llana-Ruiz-Cabello M, Gutiérrez-Praena D, Pichardo S, Moreno FJ, Bermúdez JM, Aucejo S, Cameán AM. 2014. Cytotoxicity and morphological effects induced by carvacrol and thymol on the human cell line Caco-2. Food Chem Toxicol. 64:281–290. doi:10.1016/j.fct.2013.12.005
  • Mahato N, Wu X, Wang L. 2016. Management of peri-implantitis: a systematic review, 2010-2015. Springerplus. 5:105. doi:10.1186/s40064-016-1735-2
  • Mehdi SJ, Ahmad A, Irshad M, Manzoor N, Rizvi MMA. 2011. Cytotoxic effect of carvacrol on human cervical cancer cells. Biol Med. 3:307–312.
  • Mellado-Valero A, Buitrago-Vera P, Solá-Ruiz MF, Ferrer-García JC. 2013. Decontamination of dental implant surface in peri-implantitis treatment: a literature review. Med Oral Patol Oral Cir Bucal. 18:869–876.
  • Melo JO, Fachin AL, Rizo WF, Jesus HC, Arrigoni-Blank MF, Alves PB, Marins MA, França SC, Blank AF. 2014. Cytotoxic effects of essential oils from three Lippia gracilis Schauer genotypes on HeLa, B16, and MCF-7 cells and normal human fibroblasts. Genet Mol Res. 13:2691–2697. doi:10.4238/2014.April.8.12
  • Miladi H, Mili D, Ben Slama R, Zouari S, Ammar E, Bakhrouf A. 2016. Antibiofilm formation and anti-adhesive property of three mediterranean essential oils against a foodborne pathogen Salmonella strain. Microb Pathog. 93:22–31. doi:10.1016/j.micpath.2016.01.017
  • Mombelli A, Decaillet F. 2011. The characteristics of biofilms in peri-implant disease. J Clin Periodontol. 38:203–213. doi:10.1111/j.1600-051X.2010.01666.x
  • Moura JS, da Silva WP, Pereira T, Del Bel Cury AA, Garcia RCR. 2006. A comparison of the antibacterial efficacies of essential oils against oral pathogens. J Prosthet Dent. 96:205–211. doi:10.1016/j.prosdent.2006.07.004
  • Nogueira MN, Aquino SG, Rossa Junior C, Spolidorio DM. 2014. Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages. Inflamm Res. 63:769–778. doi:10.1007/s00011-014-0749-x
  • Radulović NS, Blagojević PD, Stojanović-Radić ZZ, Stojanović NM. 2013. Antimicrobial plant metabolites: structural diversity and mechanism of action. Curr Med Chem. 20:932–952.
  • Ramage G, Vande Walle K, Bachmann SP, Wickes BL, López-Ribot JL. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. J. Biomed. Mater. Res. Part B Appl. Biomater 46:3634–3636. doi:10.1128/AAC.46.11.3634-3636.2002
  • Ready D, Theodoridis G, Green I, Ciric L, Pratten J, Tay W, McDonald A. 2015. In vitro evaluation of the antibiofilm properties of chlorhexidine and delmopinol on dental implant surfaces. Int J Antimicrob Agents. 45:662–666. doi:10.1016/j.ijantimicag.2015.01.020
  • Renvert S, Quirynen M. 2015. Risk indicators for peri-implantitis. A narrative review. Clin Oral Implants Res. 26:15–44. doi:10.1111/clr.12636
  • Schou S, Holmstrup P, Jørgensen T, Skovgaard LT, Stoltze K, Hjørting-Hansen E, Wenzel A. 2003. Implant surface preparation in the surgical treatment of experimental peri-implantitis with autogenous bone graft and ePTFE membrane in cynomolgus monkeys. Clin Oral Implants Res. 14:412–422. doi:10.1034/j.1600-0501.2003.00912.x
  • Shahab A, Haghighati F, Baeeri M, Jamalifar H, Abdollahi M. 2011. A clinical, microbiological and immunological comparison between subgingival irrigation with Dentol and chlorhexidine in advanced periodontitis. Arch Med Sci. 7:154–160. doi:10.5114/aoms.2011.20622
  • Takarada K, Kimizuka R, Takahashi N, Honma K, Okuda K, Kato T. 2004. A comparision of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol. 19:61–64. doi:10.1046/j.0902-0055.2003.00111.x
  • Turi M, Turi E, Koljalg S, Mikelsaar M. 1997. Influence of aqueous extracts of medicinal plants on surface hydrophobicity of Escherichia coli strains of different origin. APMIS. 105:956–962. doi:10.1111/j.1699-0463.1997.tb05107.x
  • Ungvári K, Pelsöczi IK, Kormos B, Oszkó A, Rakonczay Z, Kemény L, Radnai M, Nagy K, Fazekas A, Turzó K. 2010. Effects on titanium implant surfaces of chemical agents used for the treatment of peri-implantitis. J Biomed Mater Res B Appl Biomater. 94:222–229. doi:10.1002/jbm.b.31644
  • Yin Q, Yan F, Zu XY, Wu Y, Wu X, Liao M, Deng S, Yin L, Zhuang Y. 2012. Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology. 64:43–51. doi:10.1007/s10616-011-9389-y

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.